The histopathological distinction of lung adenocarcinoma (LADC) subtypes is subject to high inter-observer variability, which can compromise the optimal assessment of the patient prognosis. Therefore, this study developed convolutional neural networks (CNNs) capable of distinguishing LADC subtypes and predicting disease-specific survival, according to the recently established LADC tumor grades. Consensus LADC histopathological images were obtained from seventeen expert pulmonary pathologists and one pathologist in training. Two deep learning models (AI-1 and AI-2) were trained to predict eight different LADC classes. Furthermore, the trained models were tested on an independent cohort of 133 patients. The models achieved high precision, rec...
Lung cancer has a high incidence and mortality rate. The five-year relative survival rate f...
INTRODUCTION: Deep Learning has been proposed as promising tool to classify malignant nodules. Our a...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
The histopathological distinction of lung adenocarcinoma (LADC) subtypes is subject to high inter-ob...
Objectives: The subtype classification of lung adenocarcinoma is important for treatment decision. T...
Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common forms of lung cancer. T...
International audienceThe histological distinction of lung neuroendocrine carcinoma, including small...
Objectives The application of artificial intelligence (AI) to the field of pathology has facilitated...
Abstract Lung cancer is one of the major causes of cancer-related deaths in many countries around th...
Lung cancer is worldwide the second death cancer, both in prevalence and lethality, both for women a...
Tumor histology is an important predictor of therapeutic response and outcomes in lung cancer. Tissu...
The prognosis of patients with lung adenocarcinoma (LUAD), especially early-stage LUAD, is dependent...
This study aims to develop a deep neural network (DNN)-based two-stage risk stratification model for...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Lung cancer is one of the deadliest cancer types whose 84% is non-small cell lung cancer (NSCLC). In...
Lung cancer has a high incidence and mortality rate. The five-year relative survival rate f...
INTRODUCTION: Deep Learning has been proposed as promising tool to classify malignant nodules. Our a...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...
The histopathological distinction of lung adenocarcinoma (LADC) subtypes is subject to high inter-ob...
Objectives: The subtype classification of lung adenocarcinoma is important for treatment decision. T...
Adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC) are the most common forms of lung cancer. T...
International audienceThe histological distinction of lung neuroendocrine carcinoma, including small...
Objectives The application of artificial intelligence (AI) to the field of pathology has facilitated...
Abstract Lung cancer is one of the major causes of cancer-related deaths in many countries around th...
Lung cancer is worldwide the second death cancer, both in prevalence and lethality, both for women a...
Tumor histology is an important predictor of therapeutic response and outcomes in lung cancer. Tissu...
The prognosis of patients with lung adenocarcinoma (LUAD), especially early-stage LUAD, is dependent...
This study aims to develop a deep neural network (DNN)-based two-stage risk stratification model for...
Lung cancer has a high incidence and mortality rate. Early detection and diagnosis of lung cancers i...
Lung cancer is one of the deadliest cancer types whose 84% is non-small cell lung cancer (NSCLC). In...
Lung cancer has a high incidence and mortality rate. The five-year relative survival rate f...
INTRODUCTION: Deep Learning has been proposed as promising tool to classify malignant nodules. Our a...
BACKGROUND: Non-small-cell lung cancer (NSCLC) patients often demonstrate varying clinical courses a...